Alteration of biopharmaceutical properties of drugs by their conjugation with water-soluble macromolecules: Uricase-dextran conjugate
- 31 January 1990
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 11 (1-3) , 149-156
- https://doi.org/10.1016/0168-3659(90)90128-g
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Soluble macromolecular carriers for the delivery of antitumour drugsAdvanced Drug Delivery Reviews, 1989
- Development of a novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. II. Disposition and pharmacokinetics following intravenous and intramuscular administrationInternational Journal of Pharmaceutics, 1987
- Development of a novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. I. Physicochemical characteristics and in vivo and in vitro antitumor activitiesInternational Journal of Pharmaceutics, 1987
- Disposition and Tumor Localization of Mitomycin C–Dextran Conjugates in MicePharmaceutical Research, 1987
- Absorption characteristics of macromolecular prodrugs of mitomycin C following intramuscular administration.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Urinary excretion characteristics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate.Journal of Pharmacobio-Dynamics, 1985
- Plasma disposition and in vivo and in vitro antiumor activities of mitomycin C-dextran conjugate in relation to the mode of action.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Regeneration characteristics of mitomycin C-dextran conjugate in relation to its activity.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Physico-chemical and antitumor characteristics of high molecular weight prodrugs of Mitomycin C.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- Mitomycin C-dextran conjugate: a novel high molecular weight pro-drug of mitomycin CJournal of Pharmacy and Pharmacology, 1980